产品简要
公司名称 :
MyBioSource
产品类型 :
抗体
产品名称 :
Monoclonal Antibody to Procollagen III N-Terminal Propeptide (PIIINP)
目录 :
MBS2025794
规格 :
0.01毫克
价格 :
130美元
克隆性 :
单克隆
宿主 :
小鼠
共轭标签 :
未共轭
克隆名称 :
[A6]
反应物种 :
人类
应用 :
免疫印迹, 免疫组化, 免疫细胞化学, 免疫沉淀
更多信息或购买 :
图像
图像 1 :
MyBioSource MBS2025794 图像 1
Western Blot; Sample: Human Hela cell lysate; Primary Ab: 6ug/ml Mouse Anti-Multi-species PIIINP Antibody
图像 2 :
MyBioSource MBS2025794 图像 2
Western Blot; Sample: Human HepG2 cell lysate;. Primary Ab: 5ug/ml Mouse Anti-Multi-species PIIINP Antibody. Secondary Ab: 0.2ug/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (MBS2086035)
图像 3 :
MyBioSource MBS2025794 图像 3
Figure. DAB staining on IHC-P; Samples: Human Stomach Tissue.
产品信息
目录号 :
MBS2025794
产品类型 :
抗体
产品全称 :
Monoclonal Antibody to Procollagen III N-Terminal Propeptide (PIIINP)
产品简称 :
[Procollagen III N-Terminal Propeptide]
其他名称 :
[collagen alpha-1(III) chain preproprotein; Collagen alpha-1(III) chain; collagen alpha-1(III) chain; collagen type III alpha 1 chain]
产品基因名称 :
[PIIINP]
其他基因名称 :
[COL3A1;COL3A1;EDS4A]
克隆性 :
m
抗体亚型 :
IgG2b Kappa
克隆 :
[A6]
宿主 :
小鼠
纯度 :
蛋白质A+蛋白质G亲和色谱
形式 :
Supplied as solution form in PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
浓度 :
0.55毫克/毫升
储存稳定性 :
Storage: Avoid repeated freeze/thaw cycles. Store at 4ºC for frequent use. Aliquot and store at -20ºC for 12 months. Stability Test: The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
检测过的应用 :
免疫印迹(免疫印迹), 免疫组化(免疫组化), 免疫细胞化学(免疫细胞化学), 免疫沉淀(免疫沉淀)
应用笔记 :
Western blotting: 0.5-5 ug/mL;1:110-1100. Immunohistochemistry: 5-20 ug/mL;1:28-110. Immunocytochemistry: 5-20 ug/mL;1:28-110. Optimal working dilutions must be determined by end user.
image1头 :
免疫印迹(免疫印迹)
image2头 :
免疫印迹(免疫印迹)
image3头 :
免疫组化(免疫组化)
image4头 :
免疫组化(免疫组化)
image4描述 :
Figure. DAB staining on IHC-P;Samples: Human Kidney Tissue
其它信息1 :
Organism Species: Homo sapiens (Human). Source: Monoclonal antibody preparation. Traits: Liquid. Immunogen: Synthetic Peptide, PIIINP conjugated to OVA.Target peptide sequence: RDVWKPEPCQICVCD
其他信息2 :
Conjugated Antibody: The APC conjugated antibody version of this item is also available as catalog #MBS2044370
NCBI GI登录号 :
4502951
NCBI登录号 :
NP_000081.1
NCBI基因登录号 :
NM_000090.3
UniProt数据库登录号 :
P02461
NCBI信号通路 :
Amoebiasis Pathway (167324); Amoebiasis Pathway (167191); Assembly Of Collagen Fibrils And Other Multimeric Structures Pathway (730306); Collagen Biosynthesis And Modifying Enzymes Pathway (645289); Collagen Formation Pathway (645288); ECM-receptor Interaction Pathway (83068); ECM-receptor Interaction Pathway (479); Endothelins Pathway (137958); Extracellular Matrix Organization Pathway (576262); Focal Adhesion Pathway (198795)
NCBI总结 :
This gene encodes the pro-alpha1 chains of type III collagen, a fibrillar collagen that is found in extensible connective tissues such as skin, lung, uterus, intestine and the vascular system, frequently in association with type I collagen. Mutations in this gene are associated with Ehlers-Danlos syndrome types IV, and with aortic and arterial aneurysms. Two transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008]
UniProt数据库总结 :
CO3A1: Collagen type III occurs in most soft connective tissues along with type I collagen. Defects in COL3A1 are a cause of Ehlers-Danlos syndrome type 3 (EDS3); also known as benign hypermobility syndrome. EDS is a connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. EDS3 is a form of Ehlers-Danlos syndrome characterized by marked joint hyperextensibility without skeletal deformity. Defects in COL3A1 are the cause of Ehlers-Danlos syndrome type 4 (EDS4). EDS is a connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. EDS4 is the most severe form of the disease. It is characterized by the joint and dermal manifestations as in other forms of the syndrome, characteristic facial features (acrogeria) in most patients, and by proneness to spontaneous rupture of bowel and large arteries. The vascular complications may affect all anatomical areas. Defects in COL3A1 are a cause of susceptibility to aortic aneurysm abdominal (AAA). AAA is a common multifactorial disorder characterized by permanent dilation of the abdominal aorta, usually due to degenerative changes in the aortic wall. Histologically, AAA is characterized by signs of chronic inflammation, destructive remodeling of the extracellular matrix, and depletion of vascular smooth muscle cells. Belongs to the fibrillar collagen family. 2 isoforms of the human protein are produced by alternative splicing. Protein type: Cell adhesion; Extracellular matrix; Motility/polarity/chemotaxis; Secreted; Secreted, signal peptide. Chromosomal Location of Human Ortholog: 2q32.2. Cellular Component: collagen type III trimer; endoplasmic reticulum lumen; extracellular matrix; extracellular region; extracellular space. Molecular Function: extracellular matrix structural constituent; integrin binding; metal ion binding; platelet-derived growth factor binding; protease binding; protein binding; SMAD binding. Biological Process: aging; cell-matrix adhesion; cerebral cortex development; collagen catabolic process; collagen fibril organization; extracellular matrix organization; gut development; heart development; integrin-mediated signaling pathway; negative regulation of immune response; negative regulation of neuron migration; peptide cross-linking; platelet activation; positive regulation of Rho protein signal transduction; regulation of immune response; response to cytokine; response to mechanical stimulus; response to radiation; skeletal system development; skin development; transforming growth factor beta receptor signaling pathway; wound healing. Disease: Ehlers-danlos Syndrome, Type Iii; Ehlers-danlos Syndrome, Type Iv, Autosomal Dominant
尺寸1 :
0.01毫克
价格1 :
130美元
尺寸2 :
0.02毫克
价格2 :
140
size3 :
0.05毫克
价格3 :
190
size4 :
0.1毫克
price4 :
245
size5 :
0.2毫克
price5 :
335
size6 :
1毫克
price6 :
785
更多信息或购买 :
公司信息
MyBioSource
P.O. Box 153308
San Diego, CA 92195-3308
sales@mybiosource.com
https://www.mybiosource.com
1-858-633-0165
公司总部: 美国
MyBioSource,LLC最初由三名热情澎湃的提供高品质试剂的科学家联合创立于温哥华,公司愿景是“生物研究试剂的源头”,现在位于圣地亚哥市。